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Abstract
Background: There are several reports suggesting that hyperosmolarity induces inflammation.
We recently showed that Dextran Sodium Sulfate causes inflammatory bowel disease due to
hyperosmolarity. The aim of this study was to confirm the link between hyperosmolarity and
inflammation by assessing osmolarity values in vivo during inflammation, compare the inflammatory
potential of different osmotic agents and finally study the long-term consequences of
hyperosmolarity on cell fate.
Methods:  Osmotic pressures were measured in inflammatory liquids withdrawn from mice
subjected to inflammation caused either by subcutaneous injection of Bacille Calmette-Guérin
(BCG) or Freund adjuvant. Three epithelial cell lines (HT29, T24 and A549) were exposed up to
48 hours to increasing osmolarities (300, 600, 900 mOsm) of chemically inert molecules such as
Mannitol, Propylene Glycol, and Glycerol and inflammatory response was assessed by Enzyme
Linked ImmunoSorbent Assay (ELISA) and RNA Protection Assay (RPA). Finally, normal mouse
macrophages were exposed to hyperosmotic conditions for long-term culture.
Results:  The inflammation caused either by BCG or Freund adjuvant is correlated to
hyperosmolarity in inflammatory liquids. The exposure of cells to the different compounds,
whatever their molecular weight, has no effect on the secretion of cytokines as long as the
osmolarity is below a threshold of 300 mOsm. Higher osmolarities result in the secretion of
proinflammatory cytokines (Interleukin-8, Interleukin-6, Interleukin-1β and Tumor Necrosis
factor-α). Long-term hyperosmotic culture extends normal macrophage half-life, from 44 days to
102 days, and alters the expression of p53, Bcl-2 and Bax.
Conclusion: The present study further suggests inflammation and hyperosmolarity are closely
related phenomena if not synonymous.
Background
There are scant but reproducible reports in the literature
suggesting that hyperosmolarity can cause inflammation
[1-8]. We recently published an article showing that any
chemical, providing sufficient osmolarity can induce an
inflammation [2]. The same osmolarity of chemically
unrelated molecules, such as alanine, sodium chloride, or
Mannitol, induce similar cytokine secretion.
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In epithelial cells, such as normal colorectal epithelial
cells, the induction of proinflammatory cytokine secre-
tion through hyperosmolarity is mediated by the methyl-
ation of the catalytic subunit of Protein Phosphatase 2A
(PP2A) [2]. The methylation of PP2A, in turn, translocates
NF-κB a well-known transcription factor, which controls
the synthesis of multiple cytokines. Xylitol, a sugar
responsible for the methylation of PP2Ac, mimics the
inflammatory effect of hyperosmolarity. Okadaic acid,
which removes the methyl from PP2Ac, or specific PP2Ac
short inhibiting RNAs alleviate the effect of hyperosmo-
larity [1,2].
The idea that hyperosmolarity regulates intestinal epithe-
lial cell production of inflammatory cytokines is sup-
ported by the fact that hyperosmolarity has been reported
in several inflammatory bowel diseases. These include
Crohn's disease and ulcerative colitis [9,10], as well as the
inflammatory bowel disease of the newborn and neonatal
necrotizing enterocolitis [11]. In a previous paper [1], we
strengthened the link between inflammation and hyper-
osmolarity, showing that, in vivo, the toxicity of DSS is
mediated by hyperosmolarity. Osmolarity of DSS diluted
in drinking water below 300 mOsm had no toxic effect
while higher osmolarities of DSS caused colonic inflam-
mation. DSS-induced hyperosmolarity in turn results in
PP2A methylation, nuclear translocation of NF-κB and
the secretion of proinflammatory cytokines by colonic
epithelial cells.
The goal of this study is first to measure osmotic pressure
in the inflammatory liquids, to generalize the findings
that hyperosmolarity can cause inflammation and put for-
ward that hyperosmolarity might have long term conse-
quences on cell fate.
Methods
Chemicals
The chemical substances used were the following: D-Man-
nitol (ref 63650 Fluka), Propylene Glycol (P4347 Sigma)
and Glycerol (G2289 Sigma).
Animals and Acute Inflammation Models
BALB/c mice were obtained from the Centre d'Elevage Jan-
vier (Le Genest, St Isle, France) and maintained in accord-
ance with the European Community's guidelines
concerning the care and use of laboratory animals.
BCG-induced acute inflammation was provoked by daily
subcutaneous BCG injection (Mycobacterium bovis attenu-
ated strain) for one week (n = 6) at three doses (1, 0.1, and
0.01 mg corresponding respectively to 107, 106, and 105
bacilli) [12]. The second model of acute inflammation
was induced by Complete Freund Adjuvant (CFA, heat
inactivated Mycobacterium tuberculosis). CFA was injected
in footpad for two days (n = 6) [13]. In both models,
inflammatory liquids were withdrawn by introducing an
Hamilton's syringe under the skin and osmolarity was
measured (blood serum was used as reference) with a cry-
oscopic osmometer (Osmomat 030, Gonotec, Berlin, Ger-
many).
Cell culture
The human colon, bladder and pulmonary cancer cell
lines, HT-29, T24 and A549 (ATCC numbers HTB-38,
HTB-4, and CCL-185, LGC Promochem, Molsheim,
France) were cultured in Dulbecco's minimal essential
medium (DMEM, Gibco) supplemented with 10%
decomplemented fetal bovine serum (FBS, Eurobio, Les
Ulis, France) and 1% non-essential amino acids, in a
humid atmosphere 5% of CO2 at 37°C. Cells were plated
at a density of 105 cells per well in 6 wells-plates 48 hours
before treatment. Each well was treated during 24 or 48
hours with one of the 6 compounds of interest, with two
different concentrations per compound (corresponding
to 600 or 900 mOsm as compared to control 300 mOsm).
Osmolarities of the culture medium were measured using
a cryoscopic osmometer (Osmomat 030, GONOTEC
GmbH, Berlin, Germany). At the end of incubation,
supernatants and cells were collected in each plate and
pro-inflammatory cytokines were quantified by Enzyme
Linked ImmunoSorbent Assay (ELISA) and RNA Protec-
tion Assay (RPA).
Determination of Cytokine Levels
IL-8, IL-6, IL-1β, TNF-α secretions into the supernatants of
control or treated HT-29, T24 or A549 cells were quanti-
fied by Enzyme Linked ImmunoSorbent Assay (ELISA) by
using DuoSet ELISA kits (R&D Systems, Minneapolis,
MN), according to the manufacturer's instructions. Color-
imetric results were read in an MRX Dynatech Microplate
reader (Dynatech, Chantilly, VA) at a wavelength of 450
nm in 96-well high-binding Stripwell Costar EIA micro-
plates (Costar 2592). Substrate Reagent Pack (Catalog #
DY999, R&D Systems, Minneapolis, MN) was used for all
Streptavidin-HRP reactions. Each sample was assayed in
duplicate. For more technical specifications see Abolhas-
sani [2].
Rnase Protection Assay
RNA was extracted from HT-29 or T24 cells exposed to
900 mOsm during 24 hours or from mouse macrophages
exposed to isosmotic or hyperosmotic medium using
RNeasy Kit (Qiagen). The mRNA expression was meas-
ured by the RiboQuant multiprobe RNase protection
assay (BD Biosciences Pharmingen, San Diego, CA). Tem-
plate RNA probes were transcribed using the cDNA tem-
plate sets cytokine kits containing either human TNF-α,
IL-1β, IL-8 and IL-6 or mouse Bcl-2 and Bax, according to
the manufacturer's instructions. For transcription, exceptJournal of Inflammation 2009, 6:21 http://www.journal-inflammation.com/content/6/1/21
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for Biotin-16-UTP (Roche Diagnostics, GmbH, Man-
nheim Germany) all reagents were supplied by the manu-
facturer.
PAGE of proteins
Inflammatory liquids were withdrawn from acute inflam-
mation sites and proteins were migrated on a 4.5% poly-
acrylamide gel electrophoresis (PAGE) gel. The gel was
then fixed in a methanol/acetic acid solution and soaked
in a silver nitrate solution.
Macrophage Long-term Hyperosmotic Culture
Bronchoalveolar lavage (BAL) macrophages were
obtained from 3 consecutive lavages using 1 ml of 0.9%
saline solution each by gentle instillation of BALB/c mice
lungs (about 150 mice, 6–7 weeks, female). Purity was
controlled by cytology coloration and counting. Cells
were cultivated in Dulbecco's minimal essential medium
(DMEM, Gibco) supplemented with 10% decomple-
mented fetal bovine serum (FBS, Eurobio, Les Ulis,
France), in the presence of 10 ng/ml M-CSF, penicillin-
streptomycin-gentamycin antibiotics and 1% non-essen-
tial amino acids, in a humid atmosphere with 5% CO2 at
37°C. Hyperosmolarity was obtained by adding Mannitol
up to 300 or 600 mOsm to the culture medium. The
media were changed every two days.
Wild-type p53 and Bcl-2 Level Measurement
Total protein fractions from mouse macrophages were
extracted and quantified after homogenization at 4°C in
RIPA buffer containing 0.1 ml/ml PMSF (SIGMA), 100
μM benzamidine (SIGMA) and 100 mM Na2PO4 (Pro-
labo) as protease inhibitors.
Wild type p53 levels were measured by Assay Designs' p53
TiterZyme Enzyme®  Immunometric Assay (EIA) kit as
described in manufacturer instructions. Protein samples
are briefly deposited in a microtiter plate where a mono-
clonal antibody to p53 is immobilized. After washing, a
polyclonal antibody to p53 labeled with the enzyme
Horseradish peroxidase (HRP) is added and binds to the
p53 protein captured on the plate. After washing out the
excess sample and labeled antibody, substrate is added
and reacts with HRP-labeled antibody bound to p53 cap-
tured on the plate. After a short incubation, the reaction is
stopped and the color generated is read at 450 nm.
Wild type Bcl-2 levels were measured by using the same
method but with two specific antibodies instead of a com-
mercial kit: monoclonal antibody Bcl-2 (MAB810, Clone
121529, R&D systems) and a polyclonal antibody to Bcl-
2 labeled with the enzyme HRP (sc-509, Santa Cruz).
MTT Tests
Macrophages viability was assessed every day by using a
colorimetric method based on the cleavage of the tetrazo-
lium salt, MTT, in the presence of an electron-coupling
reagent. Cells, grown in a 96-well tissue culture plate, were
incubated with the MTT solution for 4 hours. After this
incubation period, a water-insoluble formazan dye was
formed. After overnight solubilization, the formazan dye
was quantitated using an MRX Dynatech Microplate
reader (Dynatech, Chantilly, VA). The absorbance (550
nm) revealed directly correlates to the cell number.
Statistical Analysis
The non-parametric distribution-free Kruskal-Wallis test
was used to compare three or more independent groups of
sampled data. When significant differences were found,
multiple comparison tests (Tukey test) were carried out to
identify which groups are different. Dose dependence of
cytokine production was tested by means of ANOVA and
regression analysis. All statistical analyses were performed
using the GraphPad InStat version 3.0 software for Win-
dows (GraphPad Software Inc., San Diego, CA). Values
were considered statistically significant when p was less
than 0.05.
Results
The first goal of this study is to measure osmolarity in
inflammation caused either by the BCG sub-cutaneous
inflammation (Bacille Calmette-Guérin, Mycobacterium
bovis attenuated strain) and by footpad injection of CFA
(Complete Freund Adjuvant, heat inactivated Mycobacte-
rium tuberculosis). Both agents cause inflammation at site
of injection. This inflammation results in the presence of
an inflammatory fluid. In both models, acute inflamma-
tion was induced after several daily injections and inflam-
matory liquids were withdrawn. Osmolarity of these
liquids was measured as compared to blood sera and pro-
teins were migrated on a PAGE gel and stained with silver
nitrate. Figure 1A shows the osmolarity values of inflam-
matory liquids induced by BCG. The osmolarity is
enhanced from 301 mOsm, in serum, to 526 mOsm, in 1
mg BCG-induced inflammatory liquids. With 1, 0.1, and
0.01 mg of BCG, the average osmolarity values of the
inflammatory fluid are respectively 526, 521, and 497
mOsm, and are not significantly different. There is no cor-
relation between the amount of BCG bacilli used to
induce the inflammation and the level of hyperosmolar-
ity.
On Figure 1B, the osmolarity values of the extracellular
fluid withdrawn after acute CFA-induced inflammation
are displayed. The osmolarity is enhanced from 293
mOsm in serum to 412 mOsm. Here again there is hyper-
osmolarity in the inflammatory liquids.Journal of Inflammation 2009, 6:21 http://www.journal-inflammation.com/content/6/1/21
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We then analyzed the protein content of inflammatory
liquids (Figure 1C) and found out that inflammatory liq-
uids contained a high level of proteins. These proteins are
likely to be responsible, at least in part, of the hyperosmo-
larity.
The second part of the work was to confirm that hyperos-
molarity produced by chemically inert molecules could
indeed cause inflammation. We performed a large study
with glycol-derived compounds in order to assess whether
the consequences of hyperosmotic stress observed with
other products (cf. previous studies with alanine, Manni-
tol, NaCl) might be generalized [2]. We cultivated three
epithelial cell lines (colorectal HT29, bladder T24, and
pulmonary A549) in the presence of rising hyperosmotic
concentrations (600 or 900 mOsm) of glycol-derived
compounds for 24 or 48 hours and compared their effect
on the pro-inflammatory cytokine secretion. The results
obtained for the three cell lines are very similar, so, only
the data of T24 cells are presented, likewise, only the 48
hours data are presented. Mannitol (Figures 2A, 3A, 4A,
5A) provokes the production of the four pro-inflamma-
tory cytokines tested (p < 0.001 for IL-6, IL-8, TNF-α and
IL-1β secretion by T24 cells between 300 and 900mOsm
Mannitol). This effect is limited at around 600 mOsm.
Propylene Glycol (Figures 2B, 3B, 4B, 5B) and Glycerol
(Figures 2C, 3C, 4C, 5C) exhibited the same response pro-
files (p < 0.001 for IL-8 and TNF-α secretion by T24 cells
between 300 and 900 mOsm Propylene Glycol or Glyc-
erol).
To confirm the role of hyperosmolarity in the induction of
pro-inflammatory cytokines, we analyzed the RNA pro-
duction by using an Rnase Protection Assay (RPA).
Twenty-four hours after the start of the T24 and HT-29
cells' exposure to 900 mOsm, RNA was prepared for RPA
(Figure 6). We observed that the hyperosmolarity induced
by Mannitol, Propylene Glycol, and Glycerol raises the
different RNA levels of pro-inflammatory cytokine pro-
duction in a similar manner. In conclusion, whatever the
component used, hyperosmotic stimulation induces pro-
inflammatory cytokine production.
In the third part of our work, we exposed normal macro-
phages to hyperosmotic conditions for long-term culture.
BAL macrophages were prepared and cultivated in hyper-
osmotic (600 mOsm with Mannitol) versus isosmotic
conditions (300 mOsm) for several weeks. Macrophage
half-life (Figure 7A) is extended (44 days in isosmotic cul-
Figure 1
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Osmolarities and protein levels of in vivo inflammatory liquids Figure 1
Osmolarities and protein levels of in vivo inflamma-
tory liquids. Acute inflammation in mice was induced either 
by BCG (A) (Bacille Calmette-Guérin, Mycobacterium bovis 
attenuated strain) or CFA (Complete Freund Adjuvant) foot-
pad inflammation (B) as described in the Material and Meth-
ods section. Inflammatory liquids were withdrawn and 
osmolarity values measured A) (Saline [291.17–319.06]; BCG 
0.01 mg [426.09–567.37]; BCG 0.1 mg [437.07–603.99]; 
BCG 1 mg [453.22–599.81]) and B) (Saline [282.98–303.08]; 
CFA [360.90–463.83]). C) Proteins from inflammatory liquids 
were migrated on a 4.5% PAGE gel and stained with silver 
nitrate. For each group, the horizontal bar is the median. 
Upper values represent the global p-values (Kruskal-Wallis 
test). The p-value given by the Tukey test above a stripchart 
indicates the result of the comparison of this group versus 
control. CI at 95% are given in parentheses (n = 6).Journal of Inflammation 2009, 6:21 http://www.journal-inflammation.com/content/6/1/21
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Interleukin-8 secretion induced by exposure to glycol-derived compounds Figure 2
Interleukin-8 secretion induced by exposure to glycol-derived compounds. IL-8 secretion (ELISA, in pg/ml) of human 
T24 cells exposed during 48 hours to increasing osmolarities (300, 600, 900 mOsm) of different compounds: A) Mannitol (300 
mOsm [141.23–287.79]; 600 mOsm [246.83–378.69]; 900 mOsm [703.31–1100.9]); B) Propylene Glycol (300 mOsm [141.23–
287.79]; 600 mOsm [360.62–568.54]; 900 mOsm [682.24–1084.7]); C) Glycerol (300 mOsm [141.23–287.79]; 600 mOsm 
[373.93–590.49]; 900 mOsm [816.79–1141.7]). For each group, the horizontal bar is the median. Upper values represent the 
global p-values (Kruskal-Wallis test). The p-value given by the Tukey test above a stripchart indicates the result of the compar-
ison of this group versus control. CI at 95% are given in parentheses (n = 5).
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Interleukin-6 secretion induced by exposure to glycol-derived compounds Figure 3
Interleukin-6 secretion induced by exposure to glycol-derived compounds. IL-6 secretion (ELISA, in pg/ml) of human 
T24 cells exposed during 48 hours to increasing osmolarities (300, 600, 900 mOsm) of different compounds: A) Mannitol (300 
mOsm [115.47–171.73]; 600 mOsm [108.12–199.79]; 900 mOsm [600.56–716.47]); B) Propylene Glycol (300 mOsm [115.47–
171.73]; 600 mOsm [183.87–207.27]; 900 mOsm [214.75–484.27]); C) Glycerol (300 mOsm [115.47–171.73]; 600 mOsm 
[178.71–205.97]; 900 mOsm [373.47–587.57]). For each group, the horizontal bar is the median. Upper values represent the 
global p-values (Kruskal-Wallis test). The p-value given by the Tukey test above a stripchart indicates the result of the compar-
ison of this group versus control. CI at 95% are given in parentheses (n = 5).
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
!
"
#
$
%
&
’
￿
￿
￿
￿
(
)
*
￿
+
￿
￿
,
￿
-
.
/
0
/
/
1
-
2
/
0
/
3
4
5
4
4
6
4
4
7
4
4
8
4
4
9
4
4
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
!
"
#
$
%
&
’
￿
￿
￿
￿
(
)
:
￿
+
￿
￿
￿
;
-
.
/
0
/
1
-
2
/
0
/
3
<
=
<
<
>
<
<
?
<
<
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
!
"
#
$
%
&
’
￿
￿
￿
￿
(
)
:
￿
+
￿
￿
￿
;
-
.
/
0
/
1
-
2
/
0
/
3Journal of Inflammation 2009, 6:21 http://www.journal-inflammation.com/content/6/1/21
Page 6 of 10
(page number not for citation purposes)
ture versus 102 days in hyperosmotic culture). By using an
MTT test (Figure 7A), we show that cell viability is
increased in hyperosmotic conditions. We then analyzed
the molecular events that might be responsible for these
changes. These macrophages have a modified p53 protein
expression as described in figure 7B: p53 level is stable (or
maybe slightly higher) during the isosmotic culture
whereas the protein is down-regulated in the hyperos-
motic culture. Conversely, the Bcl-2 protein level is stable
for a long period in hyperosmotic conditions, while it is
down-regulated in isosmotic conditions (Figure 7C).
These results were confirmed by RPA analysis of Bcl-2 and
Bax RNA (Figure 7D). We show an up-regulation of the
transcription of the pro-apoptotic gene Bax at day 21 in
isosmotic conditions, while it remains constant in hyper-
osmotic conditions. Conversely, the Bcl-2 anti-apoptotic
gene expression remains stable in hyperosmotic condi-
tions until the 63rd day of culture.
In conclusion, long-term hyperosmolarity exposure
appears to maintain the low levels of expression of p53
tumor-suppressor protein and Bax pro-apoptotic gene,
while it increased the level of Bcl-2 anti-apoptotic gene.
Discussion
Inflammation is characterized by tumor, dolor, rubor,
and calor as stated by Galen two thousand years ago.
Inflammation can be caused by factors as diverse as heat,
freezing temperature, trauma or multiple chemicals.
In most tissues, with the notable exception of the kidney,
the extracellular osmolarity is lower than the osmolarity
of the plasma. It is thought to be around 280 mOsm [14].
There are scant data on its evaluation during inflamma-
tion [15,16,9,10]. We assessed the osmolarity of the
inflammatory fluid in BCG and CFA inflammation mod-
els and found an osmolarity of 425–520 mOsm markedly
above the normal osmolarity of the extracellular fluid.
This increased osmolarity is probably due to protein
breakdown [17].
When a foreign body such as a splinter is inserted into the
epidermis, there is no inflammation. But, when this splin-
ter reaches the dermis where the capillaries lay, there is
inflammation. Vascular leak is a common feature of
inflammation. It can be caused by direct damage such as
by a foreign body, burn or necrosis. Whatever the cause of
the leak, this results in the leakage of red blood cells, leu-
kocytes, and plasmatic proteins. These proteins will, in
turn, be broken down into smaller pieces by the metabolic
enzymes. This partial digestion will release a larger
amount of osmoles, further increasing the extracellular
osmolarity. The electrophoresis shown on figure 1 con-
firms that hypothesis. In the inflammatory fluid caused
either by BCG or CFA, there is an increased concentration
of proteins.
We have previously shown both in vitro and in vivo, stud-
ying the DSS-induced colitis model [1,2], that hyperos-
molarity induces pro-inflammatory cytokine responses.
Our present work confort the hypothesis that hyperosmo-
larity and inflammation are closely correlated, if not syn-
onymous. Our "in vivo" results on inflammation caused
by BCG and CFA reinforce our findings on DSS; there is a
strong correlation between extracellular osmolarity and
inflammation. We used three different components. Man-
nitol is a polyol, similar to Xylitol and Sorbitol. It is a non-
permeating molecule, i.e., it cannot cross biological mem-
branes. Mannitol is used clinically to reduce acutely raised
intracranial pressure, e.g. after a stroke or head trauma
(although significant controversy exists over this use) and
to treat patients with renal failure [18]. Propylene Glycol
(or propane-1,2-diol) is an organic compound that is
hygroscopic and miscible with water [19]. It is widely used
as a moisturizer in medicine, cosmetics, food, toothpaste,
mouthwash, and tobacco products. Its oral toxicity is low,
so it is generally recognized as safe for use as a direct food
additive. It is metabolized by the organism into pyruvic
acid but does not cross biological membranes, a reason
for its use in cryoscopic conservation. Glycerol (or pro-
pane-1,2,3-triol) is also used in medical, pharmaceutical,
and personal care preparations, providing lubrification as
humectant. In organisms, it is a precursor for synthesis of
triacylglycerols and phospholipids and it might also enter
the pathway of glycolysis or neoglucogenesis. It is used as
a cryoprotective agent for cryoscopy as it is a low osmotic
agent that slowly crosses the membranes [20]. These three
components share the property of inducing hyperosmotic
stress, because they do not cross biological membranes
and are considered as non-toxic products. We confirm
that hyperosmolarity caused by the addition of Mannitol,
Propylene Glycol, and Glycerol induces the transcription
and the secretion of the following pro-inflammatory
cytokines Interleukin-8, Interleukin-6, Interleukin-1β,
and Tumor Necrosis factor-α. This stimulation was con-
firmed using three distinct cancer cell lines.
We cultivated normal macrophages in hyperosmotic con-
ditions in order to evaluate the long-term consequences of
hyperosmolarity. It appeared that the 600 mOsm culture
extended the macrophage half-life from 44, which is con-
sistent with the duration of macrophage primary culture
[21], to 102 days. At the molecular level, it maintained the
low levels of expression of p53 and Bax whereas it
increased the level of Bcl-2. p53 is a transcription factor
situated at the cross-roads of several signaling pathways
that are essential for cell-growth regulation and apoptosis
[22]. In normal conditions, the level of p53 in the cells is
usually limited by a constant degradation of the proteinJournal of Inflammation 2009, 6:21 http://www.journal-inflammation.com/content/6/1/21
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TNF-α secretion induced by exposure to glycol-derived compounds Figure 4
TNF-α secretion induced by exposure to glycol-derived compounds. TNF-α secretion (ELISA, in pg/ml) of human T24 
cells exposed during 48 hours to increasing osmolarities (300, 600, 900 mOsm) of different compounds: A) Mannitol (300 
mOsm [69.40–174.15]; 600 mOsm [214.92–247.70]; 900 mOsm [464.06–829.81]); B) Propylene Glycol (300 mOsm [69.40–
174.15]; 600 mOsm [90.364–236.51]; 900 mOsm [232.68–443.57]); C) Glycerol (300 mOsm [69.40–174.15]; 600 mOsm 
[140.36–351.25]; 900 mOsm [402.68–632.45]). For each group, the horizontal bar is the median. Upper values represent the 
global p-values (Kruskal-Wallis test). The p-value given by the Tukey test above a stripchart indicates the result of the compar-
ison of this group versus control. CI at 95% are given in parentheses (n = 5).
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IL-1β secretion induced by exposure to glycol-derived compounds Figure 5
IL-1β secretion induced by exposure to glycol-derived compounds. IL-1β secretion (ELISA, in pg/ml) of human T24 
cells exposed during 48 hours to increasing osmolarities (300, 600, 900 mOsm) of different compounds: A) Mannitol (300 
mOsm [31.969–75.141]; 600 mOsm [59.164–80.941]; 900 mOsm [125.69–154.45]); B) Propylene Glycol (300 mOsm [31.969–
75.141]; 600 mOsm [59.674–105.90]; 900 mOsm [97.915–195.67]); C) Glycerol (300 mOsm [31.969–75.141]; 600 mOsm 
[64.276–167.78]; 900 mOsm [66.748–251.01]). For each group, the horizontal bar is the median. Upper values represent the 
global p-values (Kruskal-Wallis test). The p-value given by the Tukey test above a stripchart indicates the result of the compar-
ison of this group versus control. CI at 95% are given in parentheses (n = 5).
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by the ubiquitin/proteasome pathway. When normal
mouse macrophages were put in culture in isosmotic con-
ditions, we show that the p53 level is slightly increased
until cell death. Consistently, in isosmotic cultures, Bcl-2,
a pro-survival protein is down-regulated while Bax, a pro-
apoptotic gene transactivated by p53, is overexpressed
[23]. However, hyperosmolarity prevents p53 and Bax
regulation as well as Bcl-2 inhibition. This suggests that
hyperosmolarity prevents apoptosis and allows macro-
phage half-life to be extended. These might be the initial
events in a cell transformation process. During inflamma-
tion, there is an influx of macrophages and a high rate of
epithelial cell death. Our data strongly suggest that hyper-
osmolarity appears to play a key role both in the recruit-
ment and the survival of macrophages. But, during
inflammation, there is also a massive cell death. Burg has
reported that epithelial cultured cell lines undergo apop-
tosis in response to various levels of hyperosmolarity [for
review, see [24]]. But, to our knowledge, no data have ever
been reported on normal macrophages in primary culture.
In vivo, inflammation is characterized by the production
of inflammatory mediators that permit the recruitment of
leukocytes, mainly mononuclear cells such as neutrophils
and macrophages. Here, we show that hyperosmolarity
such as measured in the inflammatory fluid (600 mOsm)
more than double macrophage half-life. Thus, hyperos-
molarity might be an important survival factor for macro-
phages that are present in the inflammation site.
Pro-inflammatory cytokines transcription following exposure  of HT-29 and T24 cells to glycol-derived compounds Figure 6
Pro-inflammatory cytokines transcription following 
exposure of HT-29 and T24 cells to glycol-derived 
compounds. Cytokine transcription was analyzed by RNase 
Protection Assay performed on RNA from human HT-29 (A) 
or T24 (B) cells exposed for 24 hours to 900 mOsm Manni-
tol (Man), Propylene Glycol (Prop) or Glycerol (Gly) media 
as compared to controls (M: normal medium; C: isosmotic 
control). Hyperosmolarity increases the level of transcription 
of IL-8, IL-6, IL-1β and TNF-α. GAPDH transcription is not 
altered.
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The consequences of hyperosmolarity may not be limited
to inflammation: first, we know that chronic infection
and inflammation contribute to about 25% of all cancer
cases worldwide [25]; second, hyperosmolarity has also
been measured in tumors [26]. This increased oncotic
pressure (osmotic pressure exerted by proteins in plasma)
has been mostly studied because it prevents the delivery
on target of anti neoplastic drugs. Distribution of antine-
oplastic agents within tumors remains one of the major
challenges in cancer chemotherapy because distribution is
hampered by high interstitial oncotic pressure [27,28]. It
is possible that cancer might also be a consequence of the
massive influx of protein leaked first during chronic
inflammation and then by the resulting abnormal blood
vessels. The resulting increased pressure may play a major
role in cancer development. This hypothesis is reinforced
by the fact that we show that hyperosmolarity down-regu-
lates the tumor suppressor gene p53 and delays apoptosis.
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Long-term hyperosmotic condition culture extends mouse  macrophages half-life and alters p53, Bax, and Bcl-2 levels Figure 7
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secutive lavages of BALB/c mice lungs. Cells were cultivated 
in Dulbecco's minimal essential medium in the presence of 10 
ng/ml M-CSF. Hyperosmolarity was obtained by adding up to 
300 or 600 mOsm Mannitol to the culture medium. Cell via-
bility (OD 450 nm) was assessed every day through an MTT 
test (A). p53 (B) and Bcl-2 (C) protein expression was meas-
ured every other day in whole protein extracts (OD 450 nm) 
as described in the Materials and Methods section. Rnase 
protection assay (RPA) of Bax and Bcl-2 was performed (D) 
(L32 is used as control). Dark triangles represent 300 mOsm 
cultures and light squares represent 600 mOsm cultures. 
Data were reproduced in three experiments, each composed 
of three independent macrophage samples. One representa-
tive experiment is presented and each point represents the 
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